MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Aging"

  • 2017 International Congress

    Prognosis and end-of-life status after emergency admissions in patients with Parkinson disease: a Japanese single center retrospective study

    K. Ikeda, K. Takahashi, K. Kawasaki, T. Furuya, A. Miyake, T. Mitsufuji, T. Fukuoka, Y. Ito, Y. Nakazato, N. Araki, T. Yamamoto (Iruma-gun, Saitama-ken, Japan)

    Objective: To investigate the status after the emergency admissions and to determine the cause and location of death in patients with Parkinson disease (PD). Background:…
  • 2017 International Congress

    Observational study of the effectiveness and tolerability of rotigotine+levodopa therapy in older vs younger Parkinson’s disease patients

    D. Woitalla, M. Asgharnejad, L. Joeres, J.-C. Schuller, K.R. Chaudhuri (Bochum, Germany)

    Objective: Prospective non-interventional study conducted in routine clinical practice (PD0013; NCT02227355) to compare effectiveness and tolerability of rotigotine+levodopa (RTG+Ldopa) in Parkinson’s disease (PD) patients aged…
  • 2017 International Congress

    Longitudinal white matter microstructural change in Parkinson’s disease

    C. Gallagher, V. Pozorski, J. Oh, F. Theisen, N. Adluru, A. Alexander (Madison, WI, USA)

    Objective: To map regional differences in rates of change in diffusion tensor imaging (DTI)-based measures of brain white matter microstructural integrity between Parkinson (PD) patients and…
  • 2016 International Congress

    Non-motor symptoms (NMS) as a determinant of caregiver burden in a cohort of older patients with Parkinson’s disease (PD)

    S. Gangadharan, N. Bareham, A. Johnson, M. Rees, A. Withenage, C.P. Padmakumar (Newcastle, Australia)

    Objective: The main goal of this study was to assess the impact of NMS burden and severity on Caregiver Burden in a cohort of older…
  • 2016 International Congress

    Vascular degeneration in Parkinson’s disease

    J. Guan, P. Yang, R.L.M. Faill, M. Dragunow, H.J. Waldvogel (Auckland, New Zealand)

    Objective: To determine the role vascular degeneration in human Parkinson's disease (PD). Background: We have previously reported endothelial degeneration in the PD. Current study examined…
  • 2016 International Congress

    Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson’s disease

    N.K. Majbour, N.N. Vaikath, K.D. Dijk, M. Ardah, C.E. Teunissen, H.W. Berendse, W.D.J. Berg, O.M.A. El-Agnaf (Amsterdam, Netherlands)

    Objective: To explore the potential use of alpha-synuclein (α-syn) species as candidate biomarkers for Parkinson's disease (PD). Background: Despite decades of intensive research, to date,…
  • 2016 International Congress

    Modulation and mechanism for the neuroprotective effects of 17-beta-estradiol: Relevance to depressive symptoms in Parkinson’s disease

    P. Kumar, N. Baquer (New Delhi, India)

    Objective: The objective of this study was to investigate neuroprotective potential of 17β estradiol (E2) treatment on the activities of acetylcholinesterase and monoamine oxidase, membrane…
  • 2016 International Congress

    Physical training prevents depressive-like behavior and bdnf decrease in an animal model of Parkinson’s disease

    T. Tuon, S.S. Valvasori, J.L. Quevedo, C.T. Souza, R.A. Pinho (Criciúma, Brazil)

    Objective: The aim of this study was to investigate the effects of two types of physical training on depressive-like behavior and pro-BDNF, BDNF and its…
  • 2016 International Congress

    Can hospital admissions predict mortality in Parkinson’s?

    B. Mohamed, N. Leopold, C. Thomas (Cardiff, United Kingdom)

    Objective: Profile patients with Parkinson's who experience inpatient care. Assess the impact of admissions to hospital and evaluate readmissions and mortality rates. Background: People with…
  • 2016 International Congress

    Assessment and connection to care: The vital role of the social worker in an interdisciplinary home visit program for advanced Parkinson’s disease patients

    M.M. Sweeney, A.C. Lemen, S.E. Oyler, R.M. Gilbert, A. Fazl, J. Chodosh, A. Di Rocco, J.E. Fleisher (New York, NY, USA)

    Objective: 1) To describe the role of social workers in managing the care coordination of homebound patients with advanced Parkinson's disease (PD); 2) to demonstrate…
  • « Previous Page
  • 1
  • …
  • 18
  • 19
  • 20
  • 21
  • 22
  • …
  • 24
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley